Company Overview
- Headquarters
- 25 Health Sciences Dr, Stony Brook NY
- Website
- icellgene.com/index.html
- Phone
- (631) 238-1908
- Employees
- 9
- Founded in
- 2014
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 54171 CompaniesNAICS Code 541714 CompaniesNAICS Code 541 CompaniesNAICS Code 5417 CompaniesNAICS Code 54 Companies
- SIC Code
-
SIC Code 873 CompaniesSIC Code 87 Companies
Financials & Stats
Revenue
$1B
Company Leadership
iCell Gene Therapeutics Tech Stack
JavaScript
HTML
PHP
Companies Similar to iCell Gene Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to iCell Gene Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 11 | 2007 | ||
| 1M | 4 | |||
| 1M | 4 | Washington, WA | 1994 | |
| 1M | 32 | New York, NY | 1983 | |
| 1M | 3 |
FAQ
What is the location of iCell Gene Therapeutics's headquarters?
The headquarters of iCell Gene Therapeutics are situated at 25 Health Sciences Dr, Stony Brook NY
What is iCell Gene Therapeutics's phone number?
iCell Gene Therapeutics's contact number is (631) 238-1908.
What is iCell Gene Therapeutics's official website?
The official website of iCell Gene Therapeutics can be found at icellgene.com/index.html.
What is iCell Gene Therapeutics's current revenue?
As of February 2019, iCell Gene Therapeutics's annual revenue reached $1B.
How many employees does iCell Gene Therapeutics currently have?
iCell Gene Therapeutics employs approximately 9+ people as of February 2019
Which industries is iCell Gene Therapeutics primarily operating in?
iCell Gene Therapeutics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the Founder and Chairman Of the Board of iCell Gene Therapeutics?
iCell Gene Therapeutics's Founder and Chairman Of the Board is Yupo Ma
When was iCell Gene Therapeutics founded?
iCell Gene Therapeutics was founded in 2014.